• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Evogene Ltd. - Ordinary Shares (NQ:EVGN)

    1.218 -0.002 (-0.13%)
    Streaming Delayed Price Updated: 2:52 PM EDT, May 14, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Evogene Ltd. - Ordinary Shares

    < Previous 1 2 3 Next >
    Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
    Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S. 
    Via Benzinga
    Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
    Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in... 
    Via Benzinga
    Evogene: Q1 Earnings Insights
    Via Benzinga
    Earnings Scheduled For May 18, 2023
    Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarterly loss at $0.04 per share on revenue of $248.01 million. 
    Via Benzinga
    Evogene's Earnings Outlook
    Via Benzinga
    Evogene 2022 Revenue Grows 80% To 1.7M
    Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) 2022 revenue was $1.7 million, an increase of 80% compared to $930,000 in 2021. Q4 Financial Highlights 
    Via Benzinga
    Evogene's Earnings Outlook
    Via Benzinga
    Preview: Evogene's Earnings
    Via Benzinga
    Recap: Evogene Q4 Earnings
    Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
    Via Benzinga
    Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
    Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
    Via Talk Markets
    Evogene Offers An Excellent Risk/Reward Ratio
    We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
    Via Talk Markets
    Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles
    Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) launched six second-generation hybrid cannabis products in Israel. 
    Via Benzinga
    Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
    Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized... 
    Via Benzinga
    Earnings Scheduled For November 17, 2022
    Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million. 
    Via Benzinga
    Canonic Launches Its High THC Medical Cannabis Products In Israel
    Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in... 
    Via Benzinga
    Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
    Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. 
    Via Benzinga
    Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
    Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year. 
    Via Benzinga
    Earnings Scheduled For August 31, 2022
    Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter. 
    Via Benzinga
    Earnings Outlook For Evogene
    Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that Evogene will... 
    Via Benzinga
    ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
    From ICL Group LTD
    Via Business Wire
    Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
    Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
    Via Benzinga
    This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
     Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... 
    Via Benzinga
    Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?
    Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the... 
    Via Benzinga
    Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
    Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending... 
    Via Benzinga
    Evogene's Earnings: A Preview
    Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Evogene will report... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! 
    Via InvestorPlace
    Earnings Scheduled For May 26, 2022
    Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million. 
    Via Benzinga
    26 Stocks Moving in Thursday's Pre-Market Session
    Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:... 
    Via Benzinga
    Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash
    Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced its 
    Via Benzinga
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.